Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124861113 | 12486111 | 3 | F | 20160516 | 20160922 | 20160621 | 20160930 | EXP | US-009507513-1606USA005616 | MERCK | 61.00 | YR | M | Y | 108.00000 | KG | 20160930 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124861113 | 12486111 | 1 | PS | PRINIVIL | LISINOPRIL | 1 | Oral | 10 MG, QD | Y | N | 19558 | 10 | MG | TABLET | QD | ||||
| 124861113 | 12486111 | 2 | SS | PRINIVIL | LISINOPRIL | 1 | Oral | 10 MG, QD | Y | N | 19558 | 10 | MG | TABLET | QD | ||||
| 124861113 | 12486111 | 3 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | Y | N | 0 | BID | |||||||
| 124861113 | 12486111 | 4 | SS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | Oral | 1000 MG, BID | Y | N | 0 | BID | |||||||
| 124861113 | 12486111 | 5 | C | ZOCOR | SIMVASTATIN | 1 | UNK | U | 0 | TABLET | |||||||||
| 124861113 | 12486111 | 6 | C | ACTOS | PIOGLITAZONE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 124861113 | 12486111 | 7 | C | KLONOPIN | CLONAZEPAM | 1 | UNK | U | 0 | ||||||||||
| 124861113 | 12486111 | 8 | C | GLIPIZIDE. | GLIPIZIDE | 1 | UNK | U | 0 | ||||||||||
| 124861113 | 12486111 | 9 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | UNK | U | 0 | CAPSULE | |||||||||
| 124861113 | 12486111 | 10 | C | LOPRESSOR | METOPROLOL TARTRATE | 1 | UNK | U | 0 | ||||||||||
| 124861113 | 12486111 | 11 | C | REMERON | MIRTAZAPINE | 1 | UNK | U | 0 | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124861113 | 12486111 | 1 | Hypertension |
| 124861113 | 12486111 | 3 | Diabetes mellitus |
| 124861113 | 12486111 | 5 | Hyperlipidaemia |
| 124861113 | 12486111 | 6 | Diabetes mellitus |
| 124861113 | 12486111 | 7 | Anxiety |
| 124861113 | 12486111 | 8 | Diabetes mellitus |
| 124861113 | 12486111 | 9 | Gastrooesophageal reflux disease |
| 124861113 | 12486111 | 10 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124861113 | 12486111 | HO |
| 124861113 | 12486111 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124861113 | 12486111 | Acute kidney injury | |
| 124861113 | 12486111 | Nephrolithiasis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124861113 | 12486111 | 1 | 2000 | 20160516 | 0 | |
| 124861113 | 12486111 | 2 | 2016 | 0 | ||
| 124861113 | 12486111 | 3 | 2000 | 20160516 | 0 | |
| 124861113 | 12486111 | 4 | 2016 | 0 |